1.5000
-0.0300
(-1.96%)
At close: January 13 at 4:00:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.63 | -0.76 | -3.37 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.98 | -0.74 | -0.53 | -0.17 |
| EPS Actual | -0.63 | -0.76 | -0.94 | -0.43 |
| Difference | 0.35 | -0.02 | -0.41 | -0.26 |
| Surprise % | 35.20% | -2.70% | -77.89% | -154.24% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CHEK | -- | -- | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 6/7/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 4/5/2023 |
| Maintains | HC Wainwright & Co.: Buy | 8/9/2021 |
| Downgrade | Dawson James: Buy to Neutral | 3/17/2021 |
| Maintains | HC Wainwright & Co.: Buy | 3/16/2021 |
Related Tickers
STIM Neuronetics, Inc.
2.3400
+36.84%
APDN Applied DNA Sciences, Inc.
0.1934
-2.18%
TTOO T2 Biosystems, Inc.
0.3200
0.00%
MYNZ Mainz Biomed N.V.
4.6700
+9.11%
OPK OPKO Health, Inc.
1.5300
+4.08%
ISPC iSpecimen Inc.
2.6800
0.00%
NDRA ENDRA Life Sciences Inc.
5.73
-2.63%
OCX OncoCyte Corporation
2.0800
-5.88%
VNRX VolitionRx Limited
0.6210
-4.75%
CSTL Castle Biosciences, Inc.
26.15
-13.55%